Assembly and activation of the plasma kallikrein/kinin system: A new interpretation

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 1841-1849

  Shariat Madar, Zia ^a   Mahdi, Fakhri ^a   Schmaier, Alvin H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Assembly and activation; Kallikrein; Kinin

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CYTOKERATIN; CYTOKERATIN 1; KININOGEN; MEMBRANE ENZYME; PLASMA KALLIKREIN; PLASMA KININ; PREKALLIKREIN; PROLINE CARBOXYPEPTIDASE; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; HIGH MOLECULAR WEIGHT KININOGEN; N ACETYL BETA GLUCOSAMINIDASE;

ARTICLE; BLOOD PRESSURE; CELL ACTIVATION; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HYPERTENSION; KALLIKREIN KININ SYSTEM; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THROMBOSIS; ANIMAL; BINDING COMPETITION; BINDING SITE; CELL MEMBRANE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CELL MEMBRANE; ENDOTHELIUM; FACTOR XI; FACTOR XII; HUMANS; KALLIKREIN-KININ SYSTEM; KININOGEN, HIGH-MOLECULAR-WEIGHT; MANNOSYL-GLYCOPROTEIN ENDO-BETA-N-ACETYLGLUCOSAMINIDASE; PLASMA KALLIKREIN; PREKALLIKREIN;

EID: 0036891713     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00178-9     Document Type: Review

References (32)

1. Motta G., Rojkjaer R., Hasan A.A.K., Cines D.B., Schmaier A.H. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood. 91:1998;516-528.
2. Zhao Y., Qiu Q., Mahdi F., Shariat-Madar Z., Rojkjaer R., Schmaier A.H. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Am. J. Physiol., Heart Circ. Physiol. 280:2001;H1821-H1829.
3. Hasan A.A.K., Zisman T., Schmaier A.H. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3615-3620.
4. Shariat-Madar Z., Mahdi F., Schmaier A.H. Mapping binding domains of kininogens on endothelial cell cytokeratin 1. J. Biol. Chem. 274:1999;7137-7145.
5. Colman R.W., Pixley R.A., Najamunnisa S., Yan W.-Y., Wang J., Mazar A.et al. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100:1997;1481-1487.
6. Joseph K., Ghebrehiwet B., Peerschke E., Reid K.B.M., Kaplan A.P. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc. Natl. Acad. Sci. U. S. A. 93:1996;8552-8557.
7. Herwald H., Dedio J., Kellner R., Loos M., Muller-Esterl W. Isolation and characterization of the kininogen binding protein p33 from endothelial cells. J. Biol. Chem. 271:1996;13040-13047.
8. Renne T., Dedio J., David G., Muller-Esterl W. High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275:2000;33688-33696.
9. Herwald H., Hasan A.A.K., Godovac-Zimmermann J., Schmaier A.H., Muller-Esterl W. Identification of an endothelial cell binding site on kininogen domain D3. J. Biol. Chem. 270:1995;14634-14642.
10. Hasan A.A.K., Cines D.B., Zhang J., Schmaier A.H. The C-terminus of bradykinin and N-terminus of the light chain of kininogens comprise an endothelial cell binding domain. J. Biol. Chem. 269:1994;31822-31830.
11. Hasan A.A.K., Cines D.B., Herwald H., Schmaier A.H., Muller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J. Biol. Chem. 270:1995;19256-19261.
12. Shariat-Madar Z., Schmaier A.H. Kininogen-cytokeratin 1 interactions in endothelial cell biology. Trends Cardiovasc. Med. 9:1999;238-244.
13. Schmaier A.H., Rojkjaer R., Shariat-Madar Z. Activation of the plasma kallikrein/kinin system on cells - A revised hypothesis. Thromb. Haemost. 82:1999;226-233.
14. Mahdi F., Shariat-Madar Z., Todd R.F. III, Figueroa C.D., Schmaier A.H. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood. 97:2001;2342-2350.
15. Shariat-Madar Z., Mahdi F., Schmaier A.H. Factor XI assembly and activation on umbilical vein endothelial cells in culture. Thromb. Haemost. 85:2001;544-551.
16. Reddigari S., Shibayama Y., Brunnee T., Kaplan A.P. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268:1993;11982-11987.
17. Mahdi F., Shariat-Madar Z., Figueroa C.D., Schmaier A.H. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood. 99:2002;3585-3596.
18. Rojkjaer R., Hasan A.A.K., Motta G., Schousboe I., Schmaier A.H. Factor XII does not initiate prekallikrein activation on the endothelial cells. Thromb. Haemost. 80:1998;74-81.
19. Motta G., Shariat-Madar Z., Mahdi F., Sampaio A.M., Schmaier A.H. Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix. Thromb. Haemost. 86:2001;840-847.
20. Shariat-Madar Z., Mahdi F., Schmaier A.H. Identification and characterization of prolylcarboxpeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277:2002;17962-17969.
21. Odya C.E., Marinkovic D.V., Hammon K.J., Stewart T.A., Erdos E.G. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J. Biol. Chem. 253:1978;5927-5931.
22. Lenich C., Pannell R., Gurewich V. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture. Thromb. Haemost. 74:1995;698-703.
23. Brown N.J., Nadeau J.H., Vaughan D.E. Selective stimulation of tissue-type plasminogen activator (tPA) in vivo by infusion of bradykinin. Thromb. Haemost. 77:1997;522-525.
24. Hong S.L. Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein. Thromb. Res. 18:1980;787-795.
25. Hasan A.A.K., Amenta S., Schmaier A.H. Bradykinin and its metabolite, ARG-PRO-PRO-GLY-PHE, are selective inhibitors of α-thrombin-induced platelet aggregation. Circulation. 94:1996;517-528.
26. Hasan A.A.K., Rebello S.S., Smith E., Srikanth S., Werns S., Driscoll E.et al. Thrombostatin inhibits induced canine coronary thrombosis. Thromb. Haemost. 82:1999;1182-1187.
27. Hasan A.A.K., Schmaier A.H., Warnock M., Normolle D., Driscoll E., Lucchesi B.R.et al. Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries. Thromb. Haemost. 86:2001;1296-1304.
28. Prieto A.R., Ma H., Huang R., Khan G., Schwartz K.A., Hage-Korban E.E.et al. Thrombostatin, a metabolite of bradykinin, reduces platelet activation in a model of arterial wall injury. Cardiovasc. Res. 53:2002;984-992.
29. Yang H.Y.T., Erdos E.G., Levin Y. A dipeptide carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim. Biophys. Acta. 214:1971;374-376.
30. Sealey J.E., Atlas S.A., Laragh J.H. Linking the kallikrein and renin systems via activation of inactive renin. New data and a hypothesis. Am. J. Med. 65:1978;994-1000.
31. Brown N.J., Vaughan D.E. Prothrombotic effects of angiotensin. Adv. Int. Med. 45:2000;419-429.
32. Schmaier A.H. J. Clin. Invest. 109:2002;1007-1009.